|
|
||||||||
1 Present address: Department of Radiology, University of Wisconsin Hospital and
Clinic, Madison, WI 53792.
2 Department of Radiology, Mayo Clinic, 200 First St. SW, Rochester, MN
55905.
Received March 4, 2004;
accepted after revision June 1, 2004.
Address correspondence to D. M. Hough.
Abstract
|
|
|---|
2 cm) simple pancreatic cystic lesions.
MATERIALS AND METHODS. A retrospective review was performed of
patients with long-term follow-up who were diagnosed with small (
2 cm)
simple pancreatic cysts on sonography or CT from 1985 to 1996. Long-term
surveillance included radiographic surveillance of 5 years or longer, clinical
follow-up of 8 years or longer, or response to questionnaire or telephone
inquiry 8 year or longer after the original diagnosis. Cause of death was
recorded for patients who died within 58 years of diagnosis. Patients
were excluded if a history of pancreatitis or systemic cystic disease
existed.
RESULTS. Seventy-nine patients had small simple pancreatic cysts. Forty-nine (62%) had adequate radiologic, clinical, or questionnaire follow-up. Of the 22 patients with radiologic follow-up, 13 (59%) had cysts that remained unchanged or became smaller (mean size, 8 mm; mean follow-up, 9 years), and nine (41%) had cysts that enlarged, from a mean of 14 mm to a mean of 26 mm (mean follow-up, 8 years). Of the 27 patients with clinical or questionnaire follow-up (mean follow-up, 10 years), none developed symptomatic pancreatic disease. Eighteen patients (23%) died within 8 years without adequate radiologic follow-up, none of pancreas-related causes. Twelve patients (15%) were lost to follow-up.
CONCLUSION. Although small, incidental, simple pancreatic cysts of 2 cm or smaller may enlarge over a prolonged time, morbidity or mortality due to these small simple cysts is extremely unlikely, and observation appears to be a safe management option.
|
|
|---|
|
|
|---|
2 cm) simple
pancreatic cysts on sonography or CT from 1985 to 1996. A cutoff of 1996 was
used to ensure adequate follow-up, which was defined as 5 years or longer of
imaging follow-up, 8 years or longer of clinical follow-up at our institution,
or follow-up via satisfactory response to a health questionnaire relating to
the history of a pancreatic disease (mailed
8 years after diagnosis).
This follow-up health questionnaire asked patients whether they had any new
diagnosis of pancreatic tumor or pancreatic disease since their last Mayo
Clinic appointment and whether they had undergone an abdominal CT, sonography,
or MRI examination. Details of any new diagnoses were obtained, and copies of
the outside imaging or medical records were sought. If patients did not
respond to the questionnaire, we attempted to contact them by telephone to
obtain the same information. To obtain clinical or imaging information from
outside institutions, we asked patients to sign an authorization for release
of medical information to our institution. Patients were excluded if they had
biochemical evidence of, or a clinical diagnosis of, pancreatitis, a history
of von Hippel-Lindau disease, polycystic disease of the kidney or liver, or
cystic fibrosis
[69];
or if they died from unrelated causes within 5 years of detection of an
incidental cyst. Clinical histories before and after cyst detection were
reviewed. Radiologic (sonographic, CT, and MRI) and endoscopic studies were
reviewed. Pathology and cytology results were reviewed when available. Causes
of death for patients who died within 5 years of the diagnosis of incidental
pancreatic cyst were delineated through mechanisms previously elucidated
(clinical history, telephone call to relatives). |
|
|---|
Table 1 summarizes the long-term follow-up of the 22 patients with radiologic studies. In the nine patients with enlarging cysts, the cysts grew at a rate of up to 8 mm/year. None of these patients became symptomatic. One additional patient with an enlarging cyst died after 3 years of congestive heart failure and is not included in this group. Of the 13 patients with radiologic follow-up who did not have cysts that enlarged, five had pancreatic cysts that were unchanged in size (Fig. 1), and eight had cysts that were not seen on follow-up CT or sonography. None of these 13 patients developed symptomatic pancreatic disease.
|
|
Table 2 summarizes the follow-up from 27 patients with clinical follow-up material at our institution or with questionnaire follow-up. None of these patients had any symptomatic or other evidence of pancreatic disease.
|
Eighteen patients died within 8 years (mean, 3.4 years; range, 1 month7 years) of the detection of their simple pancreatic cyst. Relatives indicated that there was no known pancreatic disease in any of these patients (Table 3). Only two patients were found to have had autopsies, and no pancreatic abnormality was mentioned in either autopsy report.
|
|
|
|---|
The differential diagnosis of a small and simple pancreatic cyst is broad, and such cysts may be neoplastic or nonneoplastic. Neoplastic causes include mucinous cystic neoplasm (MCN), branch duct intraductal papillary mucinous neoplasm (IPMN), and serous cystadenoma. Other cystic neoplasms such as cystic islet cell neoplasms, cystic degeneration of ductal adenocarcinoma, and solid pseudopapillary neoplasm of the pancreas are rare. Nonneoplastic cysts may be congenital, such as cysts associated with von Hippel-Lindau disease, polycystic kidney disease, and cystic fibrosis. The rare true cysts and lymphoepithelial cysts are also nonneoplastic. Nonneoplastic acquired cysts include pancreatic pseudocysts, retention cysts, and parasitic cysts [3]. Although most incidentally discovered pancreatic cysts of 2 cm or larger are neoplastic, and 50% of incidental cysts smaller than 2 cm are considered by some to be IPMN or MCN, which are presumably premalignant lesions [2], fewer than 5% of incidental pancreatic cysts smaller than 2 cm are frankly malignant [2]. Cysts with complex features such as internal septa, mural nodules, or mural enhancement have a greater likelihood of being malignant and were excluded from our study.
In their recent study, Fernandez-del Castillo et al. [2] recommend that patients with incidental pancreatic cystic lesions smaller than 2 cm should be observed, whereas those with cystic lesions greater than 2 cm should be managed according to age, with young and middle-aged patients undergoing resection. Older or less medically fit patients could undergo endoscopic sonography with fine-needle aspiration and resection only if mucin; a high level of carcinoembryonic antigen; or mucinous epithelium, malignant cells, or neuroendocrine cells were present in the aspirate. If small cystic lesions enlarge on follow-up imaging, further workup can be initiated once a cyst becomes 2 cm, with our evidence supporting the fact that this period of observation does not portend an adverse outcome for the patient. Many neoplasms responsible for an incidental pancreatic cystic lesion grow slowly and are more likely to be benign than malignant (e.g., serous cystadenoma and branch duct IPMN). In patients with benign disease, close observation will hopefully obviate unnecessary surgery.
We observed a lack of consistency in the follow-up of patients in our institution. In part, this appeared to stem from differing recommendations by radiologists who interpreted the scansfor example, whether the radiologist recommended either referral to a pancreatic specialist or follow-up imaging, or merely described the cystic lesion but made no recommendations. Follow-up intervals recommended by the radiologists were variable, and in many cases subsequent scanning was performed for an indication other than pancreatic cyst. This is probably a fair reflection of what happens in the wider community, because no accepted guidelines exist for the management of these small simple pancreatic cystic lesions. Either the patients in our study were followed up with surveillance by way of transabdominal imaging, or their cystic lesions were considered to be benign and were not further pursued. One patient underwent ERCP, which was unable to further characterize the cystic lesion, but none had endoscopic sonography or cyst aspiration. However, endoscopic sonography was not in common use during the years covered by our study.
Endoscopic sonography is now used widely in some centers, and many patients with pancreatic cystic lesions at our institution now undergo endoscopic sonography unless age or comorbidity makes it irrelevant. In addition to assessment for internal septa and mural nodules, endoscopic sonography can assess for ductal communication [10, 11]; and with endoscopic sonography guidance, it is possible to perform fine-needle aspiration of a cyst's contents [12].
The presence of mucinous epithelial cells distinguishes IPMN and MCN from serous cystic neoplasm and pseudocyst [13]. In contrast, the presence of glycogen-containing cells is diagnostic of serous cystadenoma [14, 15]. Unfortunately, the sensitivity of fine-needle aspiration to correctly diagnose the cause of these lesions is unknown. Analysis of cyst contents for viscosity, mucus, amylase, carcinoembryonic antigen, CA-125, and other tumor markers may help in further refining the diagnosis [13, 16]; however, results are often inconclusive. Typically, at our institution, an asymptomatic cyst of smaller than 1 cm will be followed up with sonography or CT. Asymptomatic cysts of about 12.5 cm will be evaluated with endoscopic sonography and, often, with fine-needle aspiration. Patients with asymptomatic cysts greater than 2.5 cm and patients with symptomatic cysts of any size may be offered surgery.
Our study has several weaknesses. The principal limitation of our study is the lack of pathologic diagnosis of these cystic lesions. However, although the cysts could have been neoplastic, and 10 cysts are known to have increased in size, it is important that none caused any morbidity or mortality. Because we could not ethically perform a prospective study in which pathologic proof was obtained, it was necessary to rely on long-term imaging and clinical follow-up. Another shortcoming caused by the necessity for prolonged follow-up is the technical limitations of older imaging technology, with the CT and sonographic equipment of 819 years ago being inferior to today's scanners. With the higher resolution of modern imaging technology, more and smaller lesions are likely to be detected than was the case in our study period. Our ability to characterize these lesions accurately as being simple versus complex cystic masses is greater now than it was in the past. Therefore, we would expect that patient outcomes should, if anything, be better in patients who are followed now by surveillance imaging than in our study patients.
Finally, an inherent limitation of this study is the potential for bias related to patients lost to follow-up. It is possible that a patient could have been diagnosed at our institution as having a simple pancreatic cyst and then experienced mortality or morbidity and returned to a local medical provider, unknown to our study. In addition, some patients were excluded on the basis of death within 8 years of diagnosis due to causes unrelated to the pancreas before sufficient follow-up could be obtained. Although we could find no evidence of pancreatic disease in our follow-up, it is difficult to completely exclude the possibility of pancreas-related disease in these patients.
In conclusion, an incidentally discovered simple pancreatic cystic lesion of 2 cm or smaller is highly unlikely to cause morbidity or mortality and, if confirmed to be a simple cystic lesion by high-quality transabdominal sonography, thin-collimation CT, MRI, or endoscopic sonography, it may safely be observed. About half of these lesions may eventually grow to be larger than 2 cm, at which time more invasive management may be required.
|
|
|---|
This article has been cited by other articles:
![]() |
H. J. Kim, D. H. Lee, Y. T. Ko, J. W. Lim, H. C. Kim, and K. W. Kim CT of Serous Cystadenoma of the Pancreas and Mimicking Masses Am. J. Roentgenol., February 1, 2008; 190(2): 406 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-W. Tien, R.-H. Hu, J.-S. Hung, H.-P. Wang, and P.-H. Lee Noninvasive Pancreatic Cystic Neoplasms can be Safely and Effectively Treated by Limited Pancreatectomy Ann. Surg. Oncol., January 1, 2008; 15(1): 193 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D'Onofrio, A. J. Megibow, N. Faccioli, R. Malago, P. Capelli, M. Falconi, and R. P. Mucelli Comparison of Contrast-Enhanced Sonography and MRI in Displaying Anatomic Features of Cystic Pancreatic Masses Am. J. Roentgenol., December 1, 2007; 189(6): 1435 - 1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Visser, B. M. Yeh, A. Qayyum, L. W. Way, C. E. McCulloch, and F. V. Coakley Characterization of Cystic Pancreatic Masses: Relative Accuracy of CT and MRI Am. J. Roentgenol., September 1, 2007; 189(3): 648 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Katz, D. M. Friedel, D. Kho, N. Georgiou, and J. J. Hines Relative Accuracy of CT and MRI for Characterization of Cystic Pancreatic Masses Am. J. Roentgenol., September 1, 2007; 189(3): 657 - 661. [Full Text] [PDF] |
||||
![]() |
B. K. P. Goh, D. V. Sahani, A. Saokar, and C. F.-d. Castillo Pancreatic Cysts 3 cm or Smaller Radiology, May 1, 2007; 243(2): 607 - 608. [Full Text] [PDF] |
||||
![]() |
J. R. Infante, H. Matsubayashi, N. Sato, J. Tonascia, A. P. Klein, T. A. Riall, C. Yeo, C. Iacobuzio-Donahue, and M. Goggins Peritumoral Fibroblast SPARC Expression and Patient Outcome With Resectable Pancreatic Adenocarcinoma J. Clin. Oncol., January 20, 2007; 25(3): 319 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Sahani, R. Kadavigere, A. Saokar, C. Fernandez-del Castillo, W. R. Brugge, and P. F. Hahn Cystic Pancreatic Lesions: A Simple Imaging-based Classification System for Guiding Management RadioGraphics, November 1, 2005; 25(6): 1471 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Manoharan and M B Sheridan Neoplasms of the pancreas Imaging, September 1, 2004; 16(4): 323 - 337. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |